Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Mraz

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Haematologica|April 13, 2019
Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cellsMiroslav Boudny, Jana Zemanova, Prashant Khirsariya, et al.
Hemasphere|April 6, 2026
Casein kinase 1δ/ε inhibition suppresses CLL proliferation through cell-intrinsic and microenvironmental mechanismsAntonia Mikulova, Hana Plesingerova, Michaela Chorvatova, et al.
American Journal of Hematology|February 4, 2015
Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II studyMichael Doubek, Yvona Brychtova, Anna Panovska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter StudyBasile Stamatopoulos, Thomas Smith, Emerence Crompot, et al.
Blood Advances|May 31, 2022
High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLLGiorgia Chiodin, Samantha Drennan, Enrica A Martino, et al.
Blood|March 31, 2021
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemiaVaclav Seda, Eva Vojackova, Laura Ondrisova, et al.
Leukemia|June 14, 2024
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugsEva Hoferkova, Vaclav Seda, Sona Kadakova, et al.
Blood|November 10, 2020
miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitorsSonali Sharma, Gabriela Mladonicka Pavlasova, Vaclav Seda, et al.
Blood|September 15, 2018
Katerina Musilova, Jan Devan, Katerina Cerna, et al.
Human Cell|August 4, 2025
Establishment of Coala: a novel 3D and 2D cancer cell line derived from colorectal cancer liver metastasisSandra Mersakova, Juraj Marcinek, Dusan Brany, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Haematologica|April 13, 2019
Novel CHK1 inhibitor MU380 exhibits significant single-agent activity in TP53-mutated chronic lymphocytic leukemia cellsMiroslav Boudny, Jana Zemanova, Prashant Khirsariya, et al.
Hemasphere|April 6, 2026
Casein kinase 1δ/ε inhibition suppresses CLL proliferation through cell-intrinsic and microenvironmental mechanismsAntonia Mikulova, Hana Plesingerova, Michaela Chorvatova, et al.
American Journal of Hematology|February 4, 2015
Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II studyMichael Doubek, Yvona Brychtova, Anna Panovska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2018
The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter StudyBasile Stamatopoulos, Thomas Smith, Emerence Crompot, et al.
Blood Advances|May 31, 2022
High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLLGiorgia Chiodin, Samantha Drennan, Enrica A Martino, et al.
Blood|March 31, 2021
FoxO1-GAB1 axis regulates homing capacity and tonic AKT activity in chronic lymphocytic leukemiaVaclav Seda, Eva Vojackova, Laura Ondrisova, et al.
Leukemia|June 14, 2024
Stromal cells engineered to express T cell factors induce robust CLL cell proliferation in vitro and in PDX co-transplantations allowing the identification of RAF inhibitors as anti-proliferative drugsEva Hoferkova, Vaclav Seda, Sona Kadakova, et al.
Blood|November 10, 2020
miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitorsSonali Sharma, Gabriela Mladonicka Pavlasova, Vaclav Seda, et al.
Blood|September 15, 2018
Katerina Musilova, Jan Devan, Katerina Cerna, et al.
Human Cell|August 4, 2025
Establishment of Coala: a novel 3D and 2D cancer cell line derived from colorectal cancer liver metastasisSandra Mersakova, Juraj Marcinek, Dusan Brany, et al.
Pageof 5